KNOTT DAVID M - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
KNOTT DAVID M ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$2,087,000
-14.5%
312,492
+9.1%
0.76%
-12.7%
Q2 2021$2,441,000
-0.2%
286,554
+3.6%
0.87%
-17.1%
Q1 2021$2,447,000
-32.5%
276,535
-6.3%
1.05%
-36.2%
Q4 2020$3,626,000
+61.8%
295,035
+7.1%
1.64%
+24.8%
Q3 2020$2,241,000
-11.5%
275,348
+4.4%
1.32%
-4.8%
Q2 2020$2,532,000
+41.2%
263,7480.0%1.38%
+22.1%
Q1 2020$1,793,000
-48.7%
263,748
+12.5%
1.13%
-20.1%
Q4 2019$3,493,000
+45.4%
234,4480.0%1.42%
+40.2%
Q3 2019$2,403,000
+4.5%
234,448
+8.1%
1.01%
+4.1%
Q2 2019$2,300,000
+25.3%
216,969
+65.2%
0.97%
+32.5%
Q1 2019$1,836,000
+37.6%
131,3330.0%0.73%
+16.7%
Q4 2018$1,334,000
+10.4%
131,333
+30.5%
0.63%
+59.9%
Q3 2018$1,208,000
+7.9%
100,669
+9.7%
0.39%
-6.7%
Q2 2018$1,120,000
+83.9%
91,769
+48.4%
0.42%
+67.3%
Q1 2018$609,000
+98.4%
61,857
+181.2%
0.25%
+105.7%
Q4 2017$307,000
+158.0%
22,000
+103.7%
0.12%
+139.2%
Q3 2017$119,00010,8000.05%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders